Katie is the co-founder and CEO of bluDiagnostics, a medical device company focused on women’s health that developed cutting edge technology enabling at-home biomarker measurements. bluDiagnostics was acquired by Amazon in 2020 and Katie served as a Director at Amazon until 2024.

Katie holds a BS and MS in Electrical Engineering from Stanford University, and a Ph.D. in Bioengineering from Caltech.